J&J CEO sends a clear message on the obesity drug boom
Johnson & Johnson (JNJ) just told Wall Street it will sit out the most lucrative drug race of the decade. The decision came straight from the top, at a public event in Washington, on June 16, and it surprised investors who assumed a large drugmaker like J&J would want a piece of the ...
The Source
THE STREET
Business
Why a fatal crash threatens Tesla’s stock
THE STREET·1h ago·3 min read
Business
How many employees does Micron have in 2026? Its workforce, locations & layoffs explained
THE STREET·24m ago·3 min read
Business
Hamilton Beach’s top-selling kitchen appliances are up to 31% off during Prime Day
THE STREET·58m ago·3 min read
Business
Veteran Wall Street trader sharply raises SanDisk stock price target
THE STREET·56m ago·3 min read
Related
On this beat
Business
Trump, Frustrated With High Gas Prices, Channels Biden’s Criticism of Big Oil
TWSJ·54m ago·3 min read
Business
Why a fatal crash threatens Tesla’s stock
THE STREET·1h ago·3 min read
Business
A Major U.S. Travel Rule Change Starts July 1—and It Comes With a $750 Price Tag
INC·1h ago·3 min read
Business
The FTC Just Forced One of the Largest Pest-Control Companies to Stop Using Noncompetes on 18,000 Workers
INC·1h ago·3 min read